The board of directors of Jacobson Pharma Corporation Limited announced that Ms. Wu Lai King (‘Ms. Wu’) due to health reason, has been unable to carry out her duties as the company secretary and an authorised representative of the Company under The Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. To the best of the Directors' knowledge, information and belief, having made all reasonable enquiries, the Board is not aware of any disagreement between Ms. Wu and the Board or any matter that needs to be brought to the attention of the shareholders of the Company or the Stock Exchange. To take up Ms. Wu's roles, (i) the company secretary of the Company has been changed from Ms. Wu to Mr. Yim Chun Leung (‘Mr. Yim’), an executive Director; and (ii) an authorized representative of the Company under the Listing Rules has been changed from Ms. Wu to Ms. Pun Yue Wai (‘Ms. Pun’), an executive Director, both changes with effect from 1 July 2019.